59964-94-2Relevant academic research and scientific papers
Palladium-catalyzed cross-coupling of aryl chlorides and tosylates with hydrazine
Lundgren, Rylan J.,Stradiotto, Mark
supporting information; experimental part, p. 8686 - 8690 (2011/01/08)
Hydrazine is not a problem anymore: The title transformation is the first reaction to yield aryl hydrazines through the cross-coupling of aryl chlorides and tosylates with hydrazine. An appropriately designed palladium catalyst allows this reaction to proceed rapidly under mild conditions, and with excellent chemoselectivity (see scheme; Ad=adamantyl, Ts=4-toluenesulfonyl).
Synthesis and Miticidal Activity of o-Biphenyldiazenecarboxylates
Dekeyser, Mark A.,McDonald, Paul T.,Angle, Gilbert W.
, p. 1705 - 1707 (2007/10/02)
Nine o-biphenyldiazenecarboxylates were obtained in excellent yields by the air oxidation of o-biphenylhydrazinecarboxylates, catalyzed by palladium on charcoal.The miticidal activity of the new compounds was evaluated against Tetranychus urticae.Structure-activity relationships for the screened compounds are discussed.Some of the compounds displayed greater activity than did the commercial miticide propargite. Keywords: Miticides; o-biphenyldiazenecarboxylates; Tetranychus urticae
Antiimplantation Agents: Part I - 1-Arylthiosemicarbazides
Nagarajan, K.,Talwalker, P.K.,Kulkarni, C.L.,Venkateswarlu, A.,Prabhu, S.S.,Nayak, G.V.
, p. 1243 - 1257 (2007/10/02)
Several 1-arylthiosemicarbazides, 2-arylhydrazinothiazolines and 2-arylhydrazinodihydrothiazines have been examined for their antiimplantation activity in rats.Among the active compounds, 4-methyl-1-(3,5-bistrifluoromethylphenyl)thiosemicarbazide (3, C 2696-Go) and the corresponding 4,4-dimethyl (47), ethyl (4), n-butyl (5) and allyl (6) derivatives completely inhibit implantation at doses 10, 3, 20, 20 and 30 mg/kg respectively.The 3,4-dichlorophenyl analogue (32) is effective at a dose of 30 mg/kg. 2-(3,5-Bistrifluoromethylphenyl)hydrazinothiazoline (51) and the corresponding dihydrothiazine (63) show a weaker activity.The biological profile of C 2696-Go has been investigated in detail.It appears to prevent implantation by its antiuterotropic activity and ability to inhibit desiduoma formation.
